DRUG · Mapped RxNorm record
Anastrozole
Normalized identity: anastrozoleView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer
NCT02097459
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Tamoxifen
Normalized identity: tamoxifenView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Toremifene
Normalized identity: toremifeneView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedPrognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
AnastrozoleDRUG · verified · RxNorm: anastrozole
TamoxifenDRUG · verified · RxNorm: tamoxifen
ToremifeneDRUG · verified · RxNorm: toremifene
Sponsors & collaborators
Peking Union Medical College Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02097459 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.